%0 Journal Article %A Gordon J. S. Rustin %T What Surveillance Plan Should Be Advised for Patients in Remission After Completion of First-Line Therapy for Advanced Ovarian Cancer? %D 2010 %R 10.1111/IGC.0b013e3181f63a28 %J International Journal of Gynecologic Cancer %P S27-S28 %V 20 %N Suppl 2 %X Based on the results of the Medical Research Council OVO5/European Organisation for Research and Treatment of Cancer 55955 trial, the follow-up plan I recommend for patients in remission after completion of first-line therapy for advanced ovarian cancer is appointments: every 3 months for 2 years, every 4 months on the third year, then every 6 months thereafter, and discharge if no relapse by 10 years. History and examination (not internal) should be performed at each appointment. CA-125 should only be measured if there is a suspicion of relapse or at patient's request. No scans should be performed unless clinical indication or rising CA-125. %U https://ijgc.bmj.com/content/ijgc/20/Suppl_2/S27.full.pdf